Choroidal Neovascularization Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Choroidal Neovascularization Market
Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Choroidal Neovascularization Market
  Global Industry Trends, Share, Size, Growth,
  Opportunity and Forecast 2024-2032," the global
  choroidal neovascularization market size reached
  US 6.5 Billion in 2023.
• Choroidal neovascularization (CNV) is a condition
  where abnormal new blood vessels grow in the of
  the eye under the retina. This health issue is a
  significant concern in eye care as it can lead to
  severe vision loss, often linked to age-related
  macular degeneration (AMD).
• CN when these irregular blood vessels break
  through the Bruch's membrane, a fragile barrier
  separating the choroid from the retina, causing
  fluid or blood to leak into the mac the central
  part of the retina responsible for The build-up
  of fluid and blood disrupts normal macular
  function, resulting in distorted or blurred
  vision. CNV can manifest in different types, such
  as classic CNV, occult CNV, and minimally classic
  CNV.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/choroidal-neovasculariz
  ation-market/requestsample

4
Report Description

• Global Choroidal Neovascularization Market
  Trends
• The global driven by the increasing, which is
  leading to a higher incidence of age-related
  macular degeneration and associated conditions
  like CNV. As a result, there is a growing demand
  for accurate diagnostic tools and effective
  treatment options, which is expected to intensify
  as the global population continues to age.
  Advances in diagnostic technologies, such as OCT
  and FA imaging, are improving the detection and
  diagnosis of CNV, enabling timely interventions
  like anti-VEGF therapies.
• Companies that specialize in innovative
  diagnostic solutions and imaging equipment are
  well-positioned to capitalize on this trend. The
  shift towards personalized medicine is also
  influencing the CNV market, with treatment
  strategies being tailored to individual patient
  characteristics, such as genetic profiles and
  biomarkers, to optimize outcomes and minimize
  side effects. Furthermore, to effective CNV
  treatments, implementing initiatives to simplify
  therapy approval processes and enhance
  reimbursement systems.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/choroidal-neovasculariz
  ation-market

5
Report Segmentation

• Breakup by Product Type
• Intravenous
• Intravitreal
•  
• Breakup by Type of Diagnosis
• Fluorescein Angiography (FA)
• Indocyanine Green (ICG) Angiography
• Spectral Domain Optical Coherence Tomography
  (OCT)
• Others
• Breakup by Treatment Type
• Angiogenesis Inhibitors Injection
• Photodynamic Therapy
• Laser photocoagulation

6
Report Segmentation

• Low-dose Radiation Therapy
• Surgery
• Breakup by Application
• Extreme Myopia
• Malignant Myopic Degeneration
• Age-Related Developments
• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• Bausch Health Companies Inc.
• Bayer AG
• Gilead Sciences, Inc.
• F. Hoffmann-La Roche AG
• MaaT Pharma
• Novartis AG
• Pfizer Inc.
• Quark Pharmaceuticals Inc. (SBI ALApharma Co.
  Limited)
• Regeneron Pharmaceuticals Inc.
• Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co.
  Ltd.).

8
Key Questions Answered in the Report
9
Key Questions Answered in the Report
10
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Choroidal
  Neovascularization Market    5.1    Market
  Overview    5.2    Market Performance    5.3  
   Impact of COVID-19  5.4    Market Forecast
• 6     Market Breakup by Product Type
• 6.1 Intravenous
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Intravitreal
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 7 Market Breakup by Type of Diagnosis
• 7.1 Fluorescein Angiography (FA)
• 7.1.1 Market Trends
• 7.1.2 Market Forecast       

11
Table of Contents

• 7.2 Indocyanine Green (ICG) Angiography
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 7.3 Spectral Domain Optical Coherence
  Tomography (OCT)
• 7.3.1 Market Trends
• 7.3.2 Market Forecast
• 7.4 Others
• 7.4.1 Market Trends
• 7.4.2 Market Forecast
• 8 Market Breakup by Treatment Type
• 8.1 Angiogenesis Inhibitors Injection
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Photodynamic Therapy
• 8.2.1 Market Trends
• 8.2.2 Market Forecast
• 8.3 Laser Photocoagulation
• 8.3.1 Market Trends
• 8.3.2 Market Forecast

12
Partial List of Clients
13
Partial List of Clients
14
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

15
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us